trending Market Intelligence /marketintelligence/en/news-insights/trending/bxdJXzy4A2Iecv1WRTyZhQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Emergent buys Sanofi's smallpox vaccine biz

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Emergent buys Sanofi's smallpox vaccine biz

Emergent BioSolutions Inc. completed the acquisition of Sanofi SA's smallpox vaccine ACAM2000, including two manufacturing facilities: one in Canton, Mass., and another in Rockville, Md.

The Maryland-based company paid $117.5 million in upfront cash and will pay a further $7.5 million once certain conditions are met.

Emergent will also assume responsibility for an existing 10-year contract valued at up to $425 million with the Centers for Disease Control and Prevention.

The contract has a remaining value of about $160 million for deliveries of ACAM2000 to the Strategic National Stockpile.